Swanrose plans to launch five products in health, hygiene segment

New Delhi: Betting on the health and hygiene segment, Swanrose India on Thursday launched a new hand sanitiser and plans to expand its portfolio in the coming months, according to a company official. It plans to introduce five products in the health and hygiene segment this year and is also looking to enter the South America and the Middle East markets.

The company is a wholly-owned subsidiary of US-based Swanrose Inc.

On Thursday, the company introduced the hand sanitiser under the brand name ‘Just Human‘ in India and the US markets simultaneously, claiming that it will protect the users 24 hours from getting infected with coronavirus.

Swanrose Inc CEO Roshini Sanah Jaiswal said, “it is the first hand sanitiser to provide extended protection. The 24-hour efficacy is backed by GLP Lab certification”

‘Just Human’ 24-hour hand sanitiser is made in India with proprietary US technology. The product has got USFDA registration and DCGI clearance in India, she added.

Presently, the company is getting its hand sanitiser manufactured here through a third party contract manufacturer from Punjab.

Initially, the company expects monthly sales of 1.5 crore from the Indian market.

“We are not one product company. Our vision is to grow,” she said, adding a couple of products are at the R&D stage, which will be intellectual property-protected products.

Swanrose started business in April 2020, by producing alcohol-based hand sanitisers. The first product launch was Aristocrat and Humaste, both alcohol-based hand sanitisers, in India and the USA.

Roshini Sanah Jaiswal is also the promoter and Chief Restructuring Officer of the Delhi-based liquor company Jagatjit Industries.

  • Related Posts

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    The Maharashtra Food and Drug Administration (FDA) seized 3,098.46 tonnes of food stock worth Rs 63.45 crore and suspended 954 food licences during a statewide enforcement drive in the past…

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    6-year data disclosed first time by Indian Pharmacopoeia Commission on CIC order The Indian Pharmacopoeia Commission (IPC) has, for the first time, disclosed the number of Serious Adverse Events (SAEs)…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Medicines that cure Us are making Our Environment Sick

    Medicines that cure Us are making Our Environment Sick